Compare BHST & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BHST | OCCI |
|---|---|---|
| Founded | 2007 | N/A |
| Country | Canada | United States |
| Employees | 87 | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.2M | 120.2M |
| IPO Year | N/A | N/A |
| Metric | BHST | OCCI |
|---|---|---|
| Price | $4.27 | $2.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 18.7K | ★ 545.3K |
| Earning Date | 01-01-0001 | 12-11-2023 |
| Dividend Yield | N/A | ★ 24.32% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ N/A | N/A |
| Revenue This Year | $116.40 | N/A |
| Revenue Next Year | $55.91 | $10.19 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.10 | $2.79 |
| 52 Week High | $12.80 | $7.17 |
| Indicator | BHST | OCCI |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 26.39 |
| Support Level | N/A | N/A |
| Resistance Level | $5.02 | $4.97 |
| Average True Range (ATR) | 0.23 | 0.15 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 13.39 | 1.86 |
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.